Topics

Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Lambert-Eaton Myasthenic Syndrome, Date of authorisation: 23/12/2009, Revision: 17, Status: Authorised

05:25 EDT 13 Sep 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Lambert-Eaton Myasthenic Syndrome, Date of authorisation: 23/12/2009, Revision: 17, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Lambert-Eaton Myasthenic Syndrome, Date of authorisation: 23/12/2009, Revision: 17, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Lambert-Eaton Myasthenic Syndrome, Date of authorisation: 23/12/2009, Revision: 17, Status: Authorised"

Quick Search